Table 5.
Results of weight measurement and average daily weight gain (ADWG) at 1 and 3 months (± SD) by different halofuginone lactate (HL) treatment groups.a
| HL treatment group | n (observations) | Age (days) | Weight (kg) | ADWG (g/day) |
|---|---|---|---|---|
| 1 month of age | ||||
| Not treated | 22 | 29.2 ± 4.4 | 54.1 ± 5.7 | 433.6 ± 160.2 |
| Incorrectly treated | 44 | 27.8 ± 3.8 | 53.4 ± 6.3 | 449.5 ± 168.2 |
| Correctly treated | 56 | 31.2 ± 4.6 | 53.9 ± 5.7 | 388.4 ± 122.8 |
| Total | 122 | 29.6 ± 4.5 | 53.8 ± 5.9 | 418.6 ± 148.9 |
| 3 months of age | ||||
| Not treated | 19 | 108.6 ± 12.2 | 134.5 ± 17.3 | 861.6 ± 121.0 |
| Incorrectly treated | 43 | 99.8 ± 12.9 | 120.4 ± 19.3 | 794.4 ± 129.4 |
| Correctly treated | 58 | 100.4 ± 6.6 | 117.7 ± 14.9 | 751.3 ± 123.7 |
| Total | 120 | 101.5 ± 10.6 | 121.3 ± 17.9 | 784.2 ± 130.3 |
a
I) not treated; II) treatment start was delayed or duration was < 7 days; III) treatment was done correctly (started in the first 48 h of life and lasted ≥ 7 days of treatment).